Relsys' Argus Safety™ Suite is the preferred adverse event reporting system, with more licensed users than any other drug safety software in the world. Argus Safety™ is in use at dozens of life sciences companies around the world, including:

• 21 of the Top 50 Pharma
• 8 of the Top 20 Pharma
• 2 of the largest CROs
• Numerous mid-sized and smaller pharma, biotechs and CROs.

Relsys' clients are headquarted in Europe, North America, Asia and Australia.